# Zenas BioPharma, Inc.: Form 8-K, filed Feb 13, 2026

- Company: [Zenas BioPharma, Inc.](/companies/zbio.md) (CIK 1953926)
- Form: 8-K
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 16:58 ET
- Period: 2026-02-10
- Accession: 0001104659-26-015314
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/tm266357d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/tm266357d1_8k.htm

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-015314. Last ingested by Listed: Nov 6, 2026, 16:59 ET. No prices; not investment advice.